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The Public Health Implications of the
Cost-Effectiveness of Bariatric Surgery
for Diabetes
B
ariatric surgery is one of the major
breakthroughs in diabetes care to
have emerged since the discovery of
insulin. In the 15 years since the ﬁrst ob-
servationalstudy,clinicaltrialsandobser-
vational studies of bariatric surgery in
diabetic patients have conﬁrmed the ben-
eﬁcial effects of surgery (1). Since 2000,
guidelines from the National Institutes of
Health (NIH) have recommended bariat-
ric surgery as an option for obesity treat-
mentinadultswithaBMI35kg/m
2and
a serious comorbid condition (2). In
2009, the Centers for Medicare & Medic-
aid Services ofﬁcially announced it would
cover bariatric surgery for beneﬁciaries
with morbid obesity and type 2 diabetes.
While bariatric surgery can be beneﬁcial,
it is an expensive intervention costing at
least $13,000 in the ﬁrst year (3). In light
of its high costs and potential beneﬁts,
understanding the cost-effectiveness of
bariatric surgery for diabetes is critical for
policy discussions regarding any ongoing
or additional public health investment in
bariatric surgery. The cost-effectiveness
of bariatric surgery for diabetes has been
evaluated in prior studies, but these stud-
ies have been limited by simplistic diabe-
tes models (4–6) with parameter inputs
derived from individual trials (5). Only
one previous study of Roux-en-Y gastric
bypass has accounted for the future com-
plications of diabetes (7,8), and only one
study has been conducted from the per-
spective of the U.S. (7).
InthisissueofDiabetesCare,Hoerger
et al. (9) address many of these deﬁcits
in the existing literature and report on
the most rigorously conducted cost-
effectiveness analysis of bariatric surgery
for diabetes to date. Using the Centers for
Disease Control-Research Triangle Insti-
tute (CDC-RTI) Diabetes Cost-Effective-
ness Model, the authors modeled the
potential lifetime effects of bariatric sur-
gery on diabetes by estimating rates of di-
abetes remission and relapse, as well as
diabetescomplications,deaths,costs,and
quality-adjusted life-years (QALYs). The
authors separately evaluated two forms of
bariatric surgery, gastric bypass and gas-
tric banding, which differ in surgical ap-
proach, clinical beneﬁts, and adverse
consequences. They also accounted for
thewell-knowndifferencesindiabetesre-
mission from surgery based on duration
of diabetes and type of surgery.
The authors found that bariatric sur-
gery, based on currently available data, is
cost-effectiveoverthelifetimesofseverely
obese patients with diabetes. Bypass sur-
gery had incremental cost-effectiveness
ratios (ICERs) of $7,000/QALY and
$12,000/QALY for severely obese pa-
tients with newly diagnosed and estab-
lished diabetes; banding surgery had
slightly higher ICERs of $11,000/QALY
and$13,000/QALYforthetworespective
diabetic groups. The ICERs for both sur-
geries are very favorable since values be-
low the $200,000/QALY threshold in the
U.S. are now considered cost-effective
(10). Other diabetes treatments, such as
intensive glycemic and lipid control in
comparison to conventional risk factor
control, have previously been found to
have ICERs of $41,384/QALY and
$51,889/QALY (11).
While these results are extremely
promising for bariatric surgery, the valid-
ity of this analysis and others like it de-
pends on the quality of the research in
bariatric surgery. Unfortunately, bariatric
surgery studies (12) are plagued by inad-
equate patient retention and short dura-
tionsoffollow-up.Theacceptedstandard
for patient retention in both published
studies and clinical practice is 50%,
which is far below the norm for clinical
studies in other areas of medicine. These
lowretentionratesarehighlyproblematic
because they have the potential to intro-
duce strong selection bias. Patient attri-
tion after bariatric surgery is very likely
related to satisfaction with the surgery
anditseffects.Thus,reportedresultsfrom
bariatric surgery likely overestimate rates
of diabetes remission and improvement
and underestimate costs. In conjunction
with the practice of allowing low reten-
tion rates, follow-up time for the majority
of bariatric surgery studies is less than 2
years (12). This short duration of fol-
low-up is thought to be appropriate for
most surgical research since complica-
tions usually occur within a few years of
surgery. However, bariatric surgery can
also cause lifelong side-effects such as
nutritional deﬁciencies, dumping syn-
drome, cholelithiasis, and long-term op-
erative complications, which may be
underrepresented in short-term studies
(13,14). The need for studies of the
long-term effects of bariatric surgery is
well-known, and efforts are being made
to address it. In 2005, the Longitudinal
Assessment of Bariatric Surgery project
waslaunchedunderdirectionoftheNa-
tional Institute of Diabetes and Diges-
tive and Kidney Diseases (NIDDK). In
addition, both the American Society for
Bariatric Surgery and the American Col-
lege of Surgeons are actively collecting
data from their approved bariatric sur-
gery centers (15,16). At present, long-
term data on bariatric surgery are
limited to the Swedish Obesity Study
and a few small trials.
Despite the limitations of bariatric
surgery literature, this analysis provides a
strong argument for the economic value
of bariatric surgery as a treatment for di-
abetes in the U.S. If bariatric surgery is
indeed a cost-effective treatment for dia-
betes in the U.S., can bariatric surgery
practically be provided to everyone who
would beneﬁt from it? Should bariatric
surgery be strongly advocated for these
patients?
One fundamental issue that may
hinderthewidespreadadoptionofbariat-
ric surgery for diabetes is that it may sim-
ply be considered too expensive in the
face of current health care budget con-
cerns. The study by Hoerger et al. shows
that bariatric surgery for diabetes is cost-
effective over the lifetime of the patient,
which means that adoption of bariatric
surgery will increase health care costs.
These cost concerns are undoubtedly
shared by individual payers who have
been reluctant to adopt widespread cov-
erage of the procedure (17). The payer
perspective is important for bariatric sur-
gery because the majority of the costs oc-
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the beneﬁts occur over the patient’s life-
time. Increasing coverage for bariatric
surgery for the treatment of diabetes will
require convincing payers that bariatric
surgery for diabetes will be at least cost-
effective, if not cost-saving, in the short-
term. Studies from European countries
with nationalized health care systems have
found that bariatric surgery is cost-effective
froma5-yearsocietalperspective,butthese
ﬁndings are based on much less sophisti-
cated methods for modeling diabetes and
bariatric surgery than the study by Hoerger
et al. (4,6). It may be necessary to conduct
an analysis from a 5-year perspective with
the model from the study by Hoerger et al.
in order to motivate private payers in the
U.S. to cover bariatric surgery for severely
obese adults with diabetes.
Another practical limitation to pro-
viding bariatric surgery to those who
would beneﬁt is the imbalance between
workforce supply and patient demand.
Quantiﬁcation of the bariatric surgeon
shortageischallengingsincebariatricsur-
gery is not an accredited surgical subspe-
cialty. However, it is known that most
bariatric surgeons are general surgeons
(18), and it is clear that there is a general
surgery crisis with anticipated deﬁcits of
at least 1,875 surgeons by 2020 (19).
Shortages in the number of general sur-
geons will undoubtedly translate into
shortages of bariatric surgeons. In addi-
tion to the limited surgeon supply, there
isalreadyahighdemandforbariatricsur-
geries (20), which will likely grow as
more populations are proven to beneﬁt
from bariatric surgery. Recent research
has suggested that laparoscopic banding
surgery may be appropriate for adoles-
cents(21).Additionally,thisanalysissug-
gests that bariatric surgery may be cost-
effective in diabetes populations that are
currently not mentioned in care guide-
lines (e.g., patients with BMI between 30
and 34 kg/m
2).
Apart from these ﬁnancial and work-
force constraints, the use of bariatric sur-
gery as a standard approach to treating
diabetes would represent a fundamental
shift in thinking for much of the public
health community. Bariatric surgery is an
intensive medical and highly technical
treatment for diabetes, and many in the
public health community may be reluc-
tant to embrace surgery as an approach to
addressing diabetes in the obese popula-
tion. Most of the current NIH- and CDC-
funded efforts to improve diabetes care in
the community have focused on creating
programs that improve the delivery of di-
abetes medical treatments and behavioral
therapies in health care facilities and
communities. An entire workforce of
physicians, diabetes educators, nurse
practitioners, and psychologists would
have to shift their orientation in order to
endorse bariatric surgery as a major pub-
lic health approach to diabetes treatment.
Bariatric surgery is an important
treatmentfordiabetes.However,research
withhighpatientretentionandlong-term
outcomes is needed to reduce the model
uncertainty of current cost-effectiveness
analyses. Widespread bariatric surgery
for severely obese patients with diabetes
may be limited because of increases in
overall costs, limited bariatric surgeons,
and uncertain public health support. As
promising as bariatric surgery is for im-
proving diabetes, it is unlikely to be the
sustainable treatment for diabetes and
obesity for future generations. So even in
thefaceofthiseffectivetreatment,further
research on all modalities—behavioral,
medical, and surgical—are needed in or-
der to combat the dual diabetes and obe-
sity epidemics.
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